Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Toxicity”

440 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 440 results

Testing effectiveness (Phase 2)Study completedNCT00055718
What this trial is testing

Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemia
Herbert Irving Comprehensive Cancer Center 50
Not applicableStudy completedNCT03899922
What this trial is testing

Monitoring Drug-induced Uveitis

Who this might be right for
UveitisUveitis Drug-InducedEye Diseases+1 more
Groupe Hospitalier Pitie-Salpetriere 1,000
Testing effectiveness (Phase 2)WithdrawnNCT00397501
What this trial is testing

BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerCognitive/Functional Effects+2 more
OHSU Knight Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00003089
What this trial is testing

Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLung Cancer
Sidney Kimmel Cancer Center at Thomas Jefferson University
Not applicableUnknownNCT04962438
What this trial is testing

Effects of Anti-VEGF Targeted Drugs on Patients' Blood Pressure and Endothelial Function

Who this might be right for
Cardiac ToxicityVEGFEndothelial Dysfunction
Peking University Third Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00003225
What this trial is testing

Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Jonsson Comprehensive Cancer Center 23
Testing effectiveness (Phase 2)Study completedNCT00919035
What this trial is testing

Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Oncology Specialists, S.C. 21
Testing effectiveness (Phase 2)Ended earlyNCT05517668
What this trial is testing

Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose

Who this might be right for
AcetaminophenDrug OverdoseAcetaminophen Overdose+4 more
Richard Dart, MD, PhD 29
Testing effectiveness (Phase 2)UnknownNCT03638375
What this trial is testing

TIL and Anti-PD1 in Metastatic Melanoma

Who this might be right for
Toxicity, DrugAdverse Drug EventEffects of Immunotherapy
Leiden University 34
Not applicableStudy completedNCT05923242
What this trial is testing

Translating ECHOS2 Into an mHealth Platform

Who this might be right for
Childhood CancerCardiac ToxicityPediatric Cancer
Washington University School of Medicine 73
Not applicableStudy completedNCT03543228
What this trial is testing

MyoStrain CMR for the Detection of Cardiotoxicity

Who this might be right for
CardiotoxicityHeart FailureChemotherapeutic Toxicity
Myocardial Solutions 63
Not applicableEnded earlyNCT05029154
What this trial is testing

Exercise Preconditioning in Ovarian Cancer

Who this might be right for
Ovarian Cancer
University of Virginia 8
Post-approval studies (Phase 4)WithdrawnNCT01374061
What this trial is testing

Pre Hospital Evaluation of Video Laryngoscopy

Who this might be right for
Cardiac ArrestRespiratory Distress SyndromeShock+3 more
Assistance Publique - Hôpitaux de Paris
Not applicableUnknownNCT03033186
What this trial is testing

Everolimus TDM to Predict Long Term Toxicity

Who this might be right for
Breast CancerRenal Cell CarcinomaPancreatic Neuroendocrine Tumour+2 more
Maastricht University Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT00401609
What this trial is testing

G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly Patients

Who this might be right for
Small Cell Lung Cancer
National Cancer Institute, Naples 85
Not applicableUnknownNCT03258099
What this trial is testing

Association of Genetic Polymorphisms With Capecitabine-based Chemotherapy Toxicities in Chinese Solid Tumor Patients

Who this might be right for
Solid TumorCapecitabineDrug-Related Side Effects and Adverse Reactions+2 more
Cui Yimin 2,200
Not applicableUnknownNCT04461392
What this trial is testing

Exercise Response After Revalidation in Cancer Patients

Who this might be right for
OncologyCardiac Toxicity
Universitair Ziekenhuis Brussel 191
Large-scale testing (Phase 3)Study completedNCT02182167
What this trial is testing

A Trial Of Intravenous N-Acetylcysteine In The Management Of Antituberculous Drug-Induced Hepatitis

Who this might be right for
Drug-Induced Liver Injury
University of Cape Town 102
Not applicableStudy completedNCT02278432
What this trial is testing

Evaluation of the Prophylactic Use of Omeprazole in Patients Admitted to the State Hospital of Américo Brasiliense

Who this might be right for
Omeprazole
Universidade Estadual Paulista Júlio de Mesquita Filho 427
Not applicableStudy completedNCT04916392
What this trial is testing

Observation Study of the Pharmacokinetics of Adductor Canal Block

Who this might be right for
Toxicity, Drug
The University of Hong Kong 10
Load More Results